Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.21)
# 3,787
Out of 5,114 analysts
57
Total ratings
40.54%
Success rate
-7.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $350 → $360 | $258.20 | +39.43% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $106.05 | +37.67% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $201.92 | -8.87% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $15.61 | +28.12% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $19.11 | +329.09% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $105.33 | +135.45% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $522.04 | -35.06% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.65 | +132.52% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.76 | +1,434.09% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $85.71 | +29.51% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $73.36 | +95.95% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $123.94 | -54.82% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $80.50 | -8.07% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $81.86 | -6.34% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.58 | +615.42% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $91.83 | - | 1 | Dec 12, 2019 |
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $258.20
Upside: +39.43%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $106.05
Upside: +37.67%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $201.92
Upside: -8.87%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $15.61
Upside: +28.12%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $19.11
Upside: +329.09%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $105.33
Upside: +135.45%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $522.04
Upside: -35.06%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.65
Upside: +132.52%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.76
Upside: +1,434.09%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $85.71
Upside: +29.51%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $73.36
Upside: +95.95%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $123.94
Upside: -54.82%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $80.50
Upside: -8.07%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $81.86
Upside: -6.34%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.58
Upside: +615.42%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $91.83
Upside: -